Radioembolization and Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma
This phase 2 clinical trial measures the 3-month response rate of selective internal radiotherapy combined with chemotherapy as well as toxic effects, overall and progression-free survival, and disease control rate for patients with unresectable intrahepatic cholangiocarcinoma.